MAKTABGACHA TA’LIM TASHKILOTLARIDA TAYYORLOV GURUH BOLALARNI RAVON NUTQINI O‘STIRISHGA O‘RGATISH YO‘LLARI
Keywords:
ravon nutq, diologik nutq, monologik nutq, ritm, temp, diksiya, nutq.Abstract
Ushbu maqolada maktabgacha ta’lim tashkilotlarida bolalarni ravon nutqqa o‘rgatish yo‘llari haqida ma’lumotlar berib o‘tilgan. Shuningdek nutq turlariga, tarbiyachi- pedagogning nutqi qanday bo‘lishi kerakligi haqida ham to‘xtalib o‘tilgan.
References
Sardi, J.; Scorzoni, L.; Bernardi, T.; Fusco-Almeida, A.; Mendes Giannini, M.J. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 2013, 62, 10–24. [CrossRef]
Waggoner-Fountain, L.A.; Walker, M.W.; Hollis, R.J.; Pfaller, M.A.; Ferguson, J.E., 2nd; Wenzel, R.P.; Donowitz, L.G. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin. Infect. Dis. 1996, 22, 803–808. [CrossRef] [PubMed]
Mayer, F.L.; Wilson, D.; Hube, B. Candida albicans pathogenicity mechanisms. Virulence J. 2013, 4, 119–128. [CrossRef] [PubMed]
Epstein, J.B.; Pearsall, N.N.; Truelove, E.L. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J. Clin. Microbiol. 1980, 12, 475–476. [PubMed]
Ghannoum, M.A.; Jurevic, R.J.; Mukherjee, P.K.; Cui, F.; Sikaroodi, M.; Naqvi, A.; Gillevet, P.M. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010, 6, e1000713. [CrossRef]
Fidel, P.L.; Vazquez, J.A.; Sobel, J.D. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 1999, 12, 80–96. [CrossRef]
Tintelnot, K.; Haase, G.; Seibold, M.; Bergmann, F.; Staemmler, M.; Franz, T.; Naumann, D. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J. Clin. Microbiol. 2000, 38, 1599–1608.
Greenberg, M.S.; Glick, M.; Ship, J.A. Burket Oral Medicine, 11th ed.; BC Decker: Hamilton, ON, Canada, 2008; pp. 79–84.
Williams, D.; Lewis, M. Pathogenesis and treatment of oral candidosis. J. Oral Microbiol. 2011, 3, 5771. [CrossRef]
Webb, B.C.; Thomas, C.J.; Willcox, M.D.; Harty, D.W.; Knox, K.W. Candida-associated denture stomatitis. Aetiology and management: A review. Part 3. Treatment of oral candidosis. Aust. Dent. J. 1998, 43, 244–249. [CrossRef]
Portela, M.B.; Souza, I.P.R.; Abreu, C.M.; Bertolini, M.; Holandino, C.; Alviano, C.S.; Santos, A.L.S.; Soares, R.M.A. Effect of serine-type protease of Candida spp. isolated from linear gingival erythema of HIV-positive children: Critical factors in the colonization. J. Oral Pathol. Med. 2010, 39, 753–760.
Farah, C.S.; Lynch, N.; McCullough, M.J. Oral fungal infections: An update for the general practitioner. Aust. Dent. J. 2010, 55, 48–54. [CrossRef] [PubMed]
Akpan, A.; Morgan, R. Oral candidiasis. Postgrad. Med. J. 2002, 78, 455–459. [CrossRef] [PubMed]
Van Boven, J.F.; De Jong-van den Berg, L.T.W.; Vegter, S. Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis. Drug Saf. 2013, 36, 231–236. [CrossRef] [PubMed]
Daya, A.M.; Anderson, I.; Portnof, J. Mandibular osteomyelitis associated with Candida albicans in marijuana and heroin abusers. Ann. Maxillofac. Surg. 2018, 8, 355. [CrossRef]
Keten, H.S.; Keten, D.; Ucer, H.; Yildirim, F.; Hakkoymaz, H.; Isik, O. Prevalence of oral Candida carriage and Candida species among cigarette and maras powder users. Int. J. Clin. Exp. Med. 2015, 8, 9847–9854.
Nishimaki, F.; Yamada, S.; Kawamoto, M.; Sakurai, A.; Hayashi, K.; Kurita, H. Relationship Between the Quantity of Oral Candida spp. and Systemic Condition/Diseases of the Host: Oral Candida Increases with Advancing Age and Anemia. Mycopathologia 2019. [CrossRef]
Santos, S.B.D.; Sabadin, C.E.S.; Mario, D.N.; Rigo, L.; Barbosa, D.A. Presence of Candida spp. and candidiasis in liver transplant patients. Anais Brasileiros de Dermatologia 2018, 93, 356–361.
Nadig, S.; Ashwathappa, D.; Manjunath, M.; Krishna, S.; Annaji, A.; Shivaprakash, P. A relationship between salivary flow rates and Candida counts in patients with xerostomia. J. Oral Maxillofac. Pathol. 2017, 21, 316. [CrossRef]
Mothibe, J.V.; Patel, M. Pathogenic characteristics of Candida albicans isolated from oral cavities of denture wearers and cancer patients wearing oral prostheses. Microb. Pathog. 2017, 110, 128–134. [CrossRef]
Lalla, R.V.; Patton, L.L.; Dongari-Bagtzoglou, A. Oral candidiasis: Pathogenesis, clinical presentation, diagnosis and treatment strategies. J. Calif. Dent. Assoc. 2013, 41, 263–268.
Al-Maskari, A.Y.; Al-Maskari, M.Y.; Al-Sudairy, S. Oral Manifestations and Complications of Diabetes Mellitus: A review. Sultan Qaboos Univ. Med. J. 2011, 11, 179–186. [PubMed] Nutrients 2019, 11, 2449 17 of 19
Mushi, M.F.; Bader, O.; Taverne-Ghadwal, L.; Bii, C.; Groß, U.; Mshana, S.E. Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa. J. Oral Microbiol. 2017, 9, 1317579. [CrossRef] [PubMed]
Bett, J.V.S.; Batistella, E.Â.; Melo, G.; Munhoz, E.A.; Silva, C.A.B.; Guerra, E.N.D.S.; Porporatti, A.L.; De Luca Canto, G. Prevalence of oral mucosal disorders during pregnancy: A systematic review and meta-analysis. J. Oral. Pathol. Med. 2019, 48, 270–277. [CrossRef] [PubMed]
Russo, E.; Bacci, G.; Chiellini, C.; Fagorzi, C.; Niccolai, E.; Taddei, A.; Ricci, F.; Ringressi, M.N.; Borrelli, R.; Melli, F.; et al. Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study. Front Microbiol. 2018, 8, 2699. [CrossRef]
Amedei, A.; Boem, F. I’ve Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine. Int. J. Mol. Sci. 2018, 19, 3756. [CrossRef]
Niccolai, E.; Boem, F.; Russo, E.; Amedei, A. The Gut-Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director “Microbiome”. Nutrients 2019, 11, 156. [CrossRef]
Milosevic, I.; Vujovic, A.; Barac, A.; Djelic, M.; Korac, M.; Spurnic, A.R.; Gmizic, I.; Stevanovic, O.; Djordjevic, V.; Lekic, N.; et al. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int. J. Mol. Sci. 2019, 20, 395. [CrossRef]
De Almeida, C.V.; De Camargo, M.R.; Russo, E.; Amedei, A. Role of diet and gut microbiota on colorectal cancer immunomodulation. World J. Gastroenterol. 2019, 25, 151–162. [CrossRef]
Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514. [CrossRef]
Guarner, F.; Sanders, M.E.; Eliakim, R.; Gangl, A.; Thomson, A.; Krabshuis, J.; Lemair, T.; Kaufmann, P.; de Paula, J.A.; Fedorak, R.; et al. World Gastroenterology Organisation; Global Guidelines Probiotics and Prebiotics. J. Clin. Gastroenterol. 2012, 46, 468–481. [CrossRef]
Fuller, R. Probiotics in human medicine. Gut 1991, 32, 439–442. [CrossRef] [PubMed]
Blaut, M. Relationship of prebiotics and food to intestinal microflora. Eur. J. Nutr. 2002, 41, i11–i16. [CrossRef] [PubMed]
Nagpal, R.; Wang, S.; Ahmadi, S.; Hayes, J.; Gagliano, J.; Subashchandrabose, S.; Kitzman, D.W.; Becton, T.; Read, R.; Yadav, H. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Sci. Rep. 2018, 8, 12649. [CrossRef] [PubMed]
Almeida, C.C.; Lorena, S.L.; Pavan, C.R.; Akasaka, H.M.; Mesquita, M.A. Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose-intolerant patients. Nutr. Clin. Pract. 2012, 27, 247–251. [CrossRef] [PubMed]
LeBlanc, J.G.; Milani, C.; de Giori, G.S.; Sesma, F.; van Sinderen, D.; Ventura, M. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr. Opin. Biotechnol. 2013, 24, 160–168. [CrossRef] [PubMed]
Cho, Y.A.; Kim, J. Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled Trials. Medicine 2015, 94, 1714. [CrossRef]
Collado, M.C.; Jalonen, L.; Meriluoto, J.; Salminen, S. Protection mechanism of probiotic combination against human pathogens: In vitro adhesion to human intestinal mucus. Asia Pac. J. Clin. Nutr. 2006, 15, 570–575.
Oldak, A.; Zielinska, D. Bacteriocins from lactic acid bacteria as an alternative to antibiotics. Postepy higieny i medycyny doswiadczalnej 2017, 71, 328–338.
Castagliuolo, I.; LaMont, J.T.; Nikulasson, S.T.; Pothoulakis, C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect. Immun. 1996, 64, 5225–5232.
Guo, S.; Gillingham, T.; Guo, Y.; Meng, D.; Zhu, W.; Walker, W.A.; Ganguli, K. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus Protect Intestinal Epithelial Barrier Function. J. Pediatr. Gastroenterol. Nutr. 2017, 64, 404–412. [CrossRef]
Maldonado Galdeano, C.; Cazorla, S.I.; Lemme Dumit, J.M.; Velez, E.; Perdigon, G. Beneficial Effects of Probiotic Consumption on the Immune System. Ann. Nutr. Metab. 2019, 74, 115–124. [CrossRef] [PubMed]
Wagner, R.D.; Pierson, C.; Warner, T.; Dohnalek, M.; Farmer, J.; Roberts, L.; Hilty, M.; Balish, E. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect. Immun. 1997, 65, 4165–4172. [PubMed] Nutrients 2019, 11, 2449 18 of 19
Sookkhee, S.; Chulasiri, M.; Prachyabrued, W. Lactic acid bacteria from healthy oral cavity of Thai volunteers: Inhibition of oral pathogens. J. Appl. Microbiol. 2001, 90, 172–179. [CrossRef] [PubMed]
Jørgensen, M.R.; Kragelund, C.; Jensen, P.Ø.; Keller, M.K.; Twetman, S. Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro. J. Oral Microbiol. 2017, 9, 1274582. [CrossRef] [PubMed]
Coman, M.M.; Verdenelli, M.C.; Cecchini, C.; Silvi, S.; Orpianesi, C.; Boyko, N.; Cresci, A. In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501(®), Lactobacillus paracasei IMC 502(®) and SYNBIO(®) against pathogens. J. Appl. Microbiol. 2014, 117, 518–527. [CrossRef] [PubMed]
Denkova, R.; Yanakieva, V.; Denkova, Z.; Nikolova, V.; Radeva, V. In vitro inhibitory activity of Bifidobacterium and lactobacillus strains against Candida Albicans. Bulg. J. Vet. Med. 2013, 16, 186–197.
Chew, S.Y.; Cheah, Y.K.; Seow, H.F.; Sandai, D.; Than, L.T.L. In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata. Anaerobe 2015, 34, 132–138. [CrossRef]
Vilela, S.F.; Barbosa, J.O.; Rossoni, R.D.; Santos, J.D.; Prata, M.C.; Anbinder, A.L.; Jorge, A.O.; Junqueira, J.C. Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella. Virulence 2015, 6, 29–39.
Wannun, P.; Piwat, S.; Teanpaisan, R. Purification, Characterization, and Optimum Conditions of Fermencin SD11, a Bacteriocin Produced by Human Orally Lactobacillus fermentum SD11. Appl. Biochem. Biotechnol. 2016, 179, 572–582. [CrossRef]
Matsubara, V.H.; Silva, E.G.; Paula, C.R.; Ishikawa, K.H.; Nakamae, A.E. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). Oral Dis. 2012, 18, 260–264. [CrossRef]
Hatakka, K., Ahola, A. J., Yli-Knuuttila, H., Richardson, M., Poussa, T., Meurman, J. H., & Korpela, R. (2007). Probiotics reduce the prevalence of oral candida in the elderly—A randomized controlled trial. Journal of Dental Research, 86(2), 125–130.
Li, D., Li, Q., Liu, C., Lin, M., Li, X., Xiao, X., … Zhou, H. (2014). Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. Mycoses, 57(3), 141–146
Kraft-Bodi, E., Jorgensen, M. R., Keller, M. K., Kragelund, C., & Twetman, S. (2015). Effect of probiotic bacteria on oral Candida in frail elderly. Journal of Dental Research, 94(Suppl. 9), 181S–186S.
Miyazima, T. Y., Ishikawa, K. H., Mayer, M., Saad, S., & Nakamae, A. (2017). Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT. Oral Diseases, 23(7), 919–925.
Petti, S., Tarsitani, G., & D’Arca, A. S. (2001). A randomized clinical trial of the effect of yoghurt on the human salivary microflora. Archives of Oral Biology, 46(8), 705–712.
Ishikawa, K. H., Mayer, M. P., Miyazima, T. Y., Matsubara, V. H., Silva, E. G., Paula, C. R., … Nakamae, A. E. (2015). A multispecies probiotic reduces oral Candida colonization in denture wearers. Journal of Prosthodontics, 24(3), 194–199.
Keller, M. K., & Kragelund, C. (2018). Randomized pilot study on probiotic effects on recurrent candidiasis in oral lichen planus patients. Oral Diseases, 24(6), 1107–1114. Ёёё2